GE Healthcare has introduced a new technology that aids in breast cancer diagnosis.
SenoBright Contrast Enhanced Spectral Mammography (CESM) reduces ambiguity in mammography results and allows physicians to detect and diagnose cancer even in the densest part of the breast tissue more rapidly and accurately.
The technology cuts patient waiting time from detection to diagnosis and uses X-rays at multiple energies to create two separate exposures.
SenoBright CESM is also used to detect the presence of cancer by highlighting areas where there is angiogenesis, the growth of small blood vessels associated with cancerous tumour growth.
The technology enables digital mammography systems to detect a new type of diagnostic information, says GE.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData